SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0000904454-18-000545
Filing Date
2018-08-31
Accepted
2018-08-31 12:50:33
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE SC 13D BY DOMAIN PARTNERS VII FOR OBALON THERAPEUTICS, INC. s13d_083118-obalon.htm SC 13D 359521
  Complete submission text file 0000904454-18-000545.txt   360963
Mailing Address ONE PALMER SQUARE SUITE 515 PRINCETON NJ 08542
Business Address ONE PALMER SQUARE SUITE 515 PRINCETON NJ 08542 609-683-5656
DOMAIN PARTERS VII L P (Filed by) CIK: 0001374150 (see all company filings)

IRS No.: 000000000
Type: SC 13D

Mailing Address 5421 AVENIDA ENCINAS SUITE F San Diego CA 92008
Business Address 5421 AVENIDA ENCINAS SUITE F San Diego CA 92008 858-480-2400
OBALON THERAPEUTICS INC (Subject) CIK: 0001427570 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-89741 | Film No.: 181049401
SIC: 3841 Surgical & Medical Instruments & Apparatus